Herman Bril

1.5k total citations
56 papers, 1.1k citations indexed

About

Herman Bril is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Herman Bril has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 18 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Herman Bril's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (16 papers) and T-cell and B-cell Immunology (12 papers). Herman Bril is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (16 papers) and T-cell and B-cell Immunology (12 papers). Herman Bril collaborates with scholars based in Netherlands, United States and Belgium. Herman Bril's co-authors include Hein B.A.C. Stockmann, Gerrit A. Meijer, Eric J.T. Belt, Remond J.A. Fijneman, Jeroen A.M. Beliën, R. Benner, Pien M. Delis‐van Diemen, Marianne Tijssen, Elly S.M. de Lange–de Klerk and A.T.J. Bianchi and has published in prestigious journals such as Nature, The Journal of Immunology and PLoS ONE.

In The Last Decade

Herman Bril

54 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herman Bril Netherlands	18	439	312	258	246	238	56	1.1k
Anna Novarino Italy	19	577 1.3×	294 0.9×	319 1.2×	140 0.6×	91 0.4×	43	1.1k
Thea M. Vroom Netherlands	19	421 1.0×	442 1.4×	217 0.8×	137 0.6×	160 0.7×	26	1.4k
Hui‐Lan Rao China	20	664 1.5×	259 0.8×	222 0.9×	298 1.2×	189 0.8×	44	1.1k
Darren Wheeler United States	15	262 0.6×	167 0.5×	114 0.4×	181 0.7×	285 1.2×	30	1.1k
Wolfgang Eisterer Austria	21	712 1.6×	564 1.8×	204 0.8×	122 0.5×	373 1.6×	95	1.7k
José María Sayagués Spain	23	292 0.7×	367 1.2×	108 0.4×	249 1.0×	202 0.8×	66	1.3k
Andrea Warrick United States	17	607 1.4×	499 1.6×	185 0.7×	258 1.0×	83 0.3×	25	1.2k
Cristiana Carniti Italy	21	439 1.0×	396 1.3×	314 1.2×	245 1.0×	84 0.4×	59	1.2k
Pierre Rudolph Germany	25	607 1.4×	621 2.0×	91 0.4×	139 0.6×	204 0.9×	41	1.5k
Alfonso Quintás‐Cardama United States	14	797 1.8×	473 1.5×	334 1.3×	140 0.6×	121 0.5×	23	1.3k

Countries citing papers authored by Herman Bril

Since Specialization

Citations

This map shows the geographic impact of Herman Bril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Bril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Bril more than expected).

Fields of papers citing papers by Herman Bril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herman Bril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Bril. The network helps show where Herman Bril may publish in the future.

Co-authorship network of co-authors of Herman Bril

This figure shows the co-authorship network connecting the top 25 collaborators of Herman Bril. A scholar is included among the top collaborators of Herman Bril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herman Bril. Herman Bril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coupé, Veerle M.H., et al.. (2022). KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer. BMC Cancer. 22(1). 372–372. 4 indexed citations

Rossen, Tessel M. van, Rogier E. Ooijevaar, Johan P. Kuyvenhoven, et al.. (2021). Microbiota composition and mucosal immunity in patients with asymptomatic diverticulosis and controls. PLoS ONE. 16(9). e0256657–e0256657. 12 indexed citations

Wit, Meike de, Robbert J.C. Slebos, Pien M. Delis‐van Diemen, et al.. (2020). Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. European Journal of Cancer. 144. 91–100. 13 indexed citations

Broek, Evert van den, Veerle M.H. Coupé, Thomas T. Vellinga, et al.. (2019). Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study. BMC Gastroenterology. 19(1). 146–146. 20 indexed citations

Draht, Muriel X.G., Kim M. Smits, Valérie Jooste, et al.. (2014). Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular Oncology. 8(3). 679–688. 30 indexed citations

Pas, M. H. G. M. van der, Marjolein Ankersmit, Hein B.A.C. Stockmann, et al.. (2013). Laparoscopic Sentinel Lymph Node Identification in Patients with Colon Carcinoma Using a Near-Infrared Dye: Description of a New Technique and Feasibility Study. Journal of Laparoendoscopic & Advanced Surgical Techniques. 23(4). 367–371. 41 indexed citations

Snoeren, Nikol, Benjamin L. Emmink, Marian J.A. Groot Koerkamp, et al.. (2013). Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer. British Journal of Cancer. 109(6). 1636–1647. 37 indexed citations

Belt, Eric J.T., Rebecca P. M. Brosens, Pien M. Delis‐van Diemen, et al.. (2012). Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer. Annals of Surgical Oncology. 19(S3). 682–692. 47 indexed citations

Weger, Vincent A. de, Annelies W. Turksma, Quirinus J.M. Voorham, et al.. (2011). Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer. Clinical Cancer Research. 18(3). 882–889. 54 indexed citations

10.

Krekel, N.M.A., Barbara M. Zonderhuis, Sandra Müller, et al.. (2011). Excessive Resections in Breast-Conserving Surgery: A Retrospective Multicentre Study. The Breast Journal. 17(6). 602–609. 56 indexed citations

11.

Vuylsteke, Ronald J.C.L.M., et al.. (2011). Feasibility of flowcytometric quantitation of immune effector cell subsets in the sentinel lymph node of the breast after cryopreservation. Journal of Immunological Methods. 375(1-2). 189–195. 8 indexed citations

12.

Belt, Eric J.T., E. A. te Velde, Oscar Krijgsman, et al.. (2011). High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer. Annals of Surgical Oncology. 19(4). 1222–1230. 68 indexed citations

13.

Belt, Eric J.T., Mireille F. M. van Stijn, Herman Bril, et al.. (2010). Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III. Annals of Surgical Oncology. 17(12). 3203–3211. 76 indexed citations

14.

Pool, M. Oudkerk, Pauline M. Ellerbroek, B U Ridwan, et al.. (1993). Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.. Gut. 34(1). 46–50. 103 indexed citations

15.

Baars, Johanna W., R.J. Scheper, Bert Flier, et al.. (1992). Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: A pilot study. Biotherapy. 4(4). 289–297. 8 indexed citations

16.

Claessen, A.M.E., et al.. (1991). Tumor regression and induction of anti‐tumor immunity by local chemotherapy of guinea‐pigs bearing a line‐10 hepatocarcinoma. International Journal of Cancer. 47(4). 626–632. 9 indexed citations

17.

Bril, Herman, et al.. (1989). Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation. Cancer Immunology Immunotherapy. 28(2). 131–5. 8 indexed citations

18.

Molendijk, Arthur J., et al.. (1988). Lipopolysaccharide-induced suppression of DTH-reactivity to histocompatibility antigens. I. Kinetic aspects and specificity. Immunobiology. 176(3). 255–271. 5 indexed citations

19.

Molendijk, Arthur J., et al.. (1988). Generation of suppressor T cells after local immunization with histocompatibility antigens. Cellular Immunology. 113(2). 480–493. 1 indexed citations

20.

Bril, Herman, et al.. (1984). Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.. The Journal of Immunology. 132(2). 599–604. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact